Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2012
Total Assets: $2.76B
Liabilities Breakdown FY2012
Total Liabilities: $1.52B
Asset Breakdown
Total Assets: $2.76B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $489.4M | 17.7% |
| Accounts Receivable | $143.3M | 5.2% |
| Inventory | $30.5M | 1.1% |
| Property, Plant & Equipment | $433.6M | 15.7% |
| Goodwill | $31.0M | 1.1% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.63B | 59.1% |
Liabilities Breakdown
Total Liabilities: $1.52B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $101.3M | 6.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.42B | 93.4% |